Click here to view the United Healthcare (UHC) Medical Policy Updates » March 2025 United…
BCBS Louisiana Medical Policy Updates – August 2024
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
August 2024 BCBS Louisiana Medical Policy Updates:
- Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
- Auditory Brainstem Implant
- Automatic Implantable Cardioverter Defibrillator (AICD)
- belimumab (Benlysta®)
- Botulinum Toxins
- Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
- Cognitive Rehabilitation
- Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or Bone
- Cysteamine Delayed Release Capsules, Oral Granules (Procysbi®)
- denosumab (Prolia®)
- Digital Health Therapies for Substance Abuse
- droxidopa (Northera®, generics)
- Ecallantide (Kalbitor®)
- eltrombopag (Promacta®)
- emapalumab-lzsg (Gamifant™)
- emtricitabine/tenofovir Branded Products (Descovy® ,Truvada®)
- Etranacogene Dezaparvovec (Hemgenix®)
- evinacumab-dgnb (Evkeeza™)
- Extended Release Topiramate Products
- Extracranial Carotid Angioplasty/Stenting
- Functional Endoscopic Sinus Surgery for Chronic Rhinosinusitis
- Functional Neuromuscular Electrical Stimulation
- Hematopoietic Cell Transplantation for Solid Tumors of Childhood
- Icatibant (Firazyr®, generics)
- Implantable Bone-Conduction and Bone-Anchored Hearing Aids
- Leadless Cardiac Pacemakers
- Lenacapavir (Sunlenca®)
- maralixibat oral solution (Livmarli™)
- mavacamten (Camzyos )
- Meniscal Allografts and Other Meniscal Implants
- Metreleptin (Myalept)
- Myocardial Strain Imaging
- Penicillamine (Cuprimine®)/Trientine (Syprine®), Generics
- Peripheral Subcutaneous Field Stimulation
- Plasminogen, human-tvmh (Ryplazim )
- Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
- Pyrimethamine (Daraprim®, generic)
- Remote Electrical Neuromodulation for Migraines
- resmetirom (Rezdiffra™)
- Responsive Neurostimulation for the Treatment of Refractory Partial Epilepsy
- Select Drugs for Attention Deficit Hyperactivity Disorder (ADHD)
- Select Levothyroxine Products
- spesolimab-sbzo (Spevigo ®)
- Subtalar Arthroereisis
- Sutimlimab-jome (Enjaymo )
- Teduglutide [rDNA origin] (Gattex®)
- Teplizumab-mzwv (Tzield™)
- Topical Treatments for Dry Eye Disease
- Vedolizumab (Entyvio®)
- Verkazia (cyclosporine ophthalmic emulsion)
- Verquvo™ (vericiguat)
- Vertebral Axial Decompression
- Vesicular Monoamine Transporter Type 2 Inhibitors: deutetrabenazine (Austedo™), tetrabenazine (Xenazine®), valbenazine (Ingrezza™)
- Wegovy™ (semaglutide)
- Xaciato™ (Clindamycin)
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup
Related Posts
